Transcatheter aortic valve replacement in low risk patients: a review of PARTNER 3 and Evolut low risk trials
Joao Braghiroli(Jackson Memorial Hospital), Mauricio G. Cohen(Santa Ana College), Tanira Ferreira(University of Miami), Torin P. Thielhelm(University of Miami), Kunal Kapoor(University of Miami)
Cited by 74
Related Papers
Contemporary Management of Cardiogenic Shock: A Scientific Statement From the American Heart Association
|Circulation|2017|1.8k
2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization
|Journal of the American College of Cardiology|2021|1.5k
Predictive Factors, Management, and Clinical Outcomes of Coronary Obstruction Following Transcatheter Aortic Valve Implantation
|Journal of the American College of Cardiology|2013|643
An Update on Radial Artery Access and Best Practices for Transradial Coronary Angiography and Intervention in Acute Coronary Syndrome: A Scientific Statement From the American Heart Association
|Circulation Cardiovascular Interventions|2018|519